Brief: Evolus Expands Into U.S. Dermal Filler Market With Evolysse

Evolus

09/05/2023 21:27

May 9 (Reuters) - Evolus Inc  EOLS.O :
    * EVOLUS ANNOUNCES EXPANSION INTO U.S. DERMAL FILLER MARKET
WITH
EVOLYSSE™, A FIRST-GENERATION COLD TECHNOLOGY HA BY SYMATESE
    * EVOLUS INC - PORTFOLIO OF 5 FILLERS IN LATE-STAGE
DEVELOPMENT;
FIRST APPROVAL EXPECTED IN 1H 2025
    * EVOLUS INC - RAISES 2028 REVENUE OUTLOOK FROM $500 MILLION
TO
$700 MILLION
    * EVOLUS INC - HIGHLY CAPITAL EFFICIENT DEAL STRUCTURE
FUNDED
THROUGH $50 MILLION PHARMAKON TRANCHE; COMPANY EXPECTS TO REMAIN
FULLY FUNDED TO PROFITABILITY

Source text for Eikon:  ID:nBwfKnM7a 
Further company coverage:  EOLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))